210 related articles for article (PubMed ID: 1375811)
1. Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies.
Greenberg F; Schmidt D; Darnule AT; Weyland BR; Rose E; Alpert E
Am J Obstet Gynecol; 1992 May; 166(5):1388-92. PubMed ID: 1375811
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening for trisomy 18 with free beta human chorionic gonadotrophin as a marker.
Spencer K; Mallard AS; Coombes EJ; Macri JN
BMJ; 1993 Dec; 307(6917):1455-8. PubMed ID: 7506599
[TBL] [Abstract][Full Text] [Related]
3. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
Burton BK; Prins GS; Verp MS
Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
[TBL] [Abstract][Full Text] [Related]
4. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI
Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763
[TBL] [Abstract][Full Text] [Related]
5. Very low maternal serum chorionic gonadotropin levels in association with fetal triploidy.
Schmidt D; Shaffer LG; McCaskill C; Rose E; Greenberg F
Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):77-80. PubMed ID: 7507646
[TBL] [Abstract][Full Text] [Related]
6. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
Palomaki GE; Haddow JE; Knight GJ; Wald NJ; Kennard A; Canick JA; Saller DN; Blitzer MG; Dickerman LH; Fisher R
Prenat Diagn; 1995 Aug; 15(8):713-23. PubMed ID: 7479589
[TBL] [Abstract][Full Text] [Related]
7. Elevated maternal midtrimester serum free beta-human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results.
Cheng PJ; Chu DC; Chueh HY; See LC; Chang HC; Weng DR
Am J Obstet Gynecol; 2004 Feb; 190(2):442-7. PubMed ID: 14981387
[TBL] [Abstract][Full Text] [Related]
8. First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A.
Spencer K; Aitken DA; Crossley JA; McCaw G; Berry E; Anderson R; Connor JM; Macri JN
Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():447-54. PubMed ID: 7530437
[TBL] [Abstract][Full Text] [Related]
9. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
[TBL] [Abstract][Full Text] [Related]
10. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of maternal serum screening in the prenatal detection of fetal chromosome abnormalities in Japanese women.
Kishida T; Hoshi N; Hattori R; Negishi H; Yamada H; Okuyama K; Hanatani K; Takagi T; Sagawa T; Fujimoto S
Fetal Diagn Ther; 2000; 15(2):112-7. PubMed ID: 10720877
[TBL] [Abstract][Full Text] [Related]
12. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
13. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Palomaki GE; Knight GJ; Haddow JE; Canick JA; Saller DN; Panizza DS
Prenat Diagn; 1992 Nov; 12(11):925-30. PubMed ID: 1283634
[TBL] [Abstract][Full Text] [Related]
14. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome.
Lieppman RE; Williams MA; Cheng EY; Resta R; Zingheim R; Hickok DE; Luthy DA
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1852-6; discussion 1856-7. PubMed ID: 8317532
[TBL] [Abstract][Full Text] [Related]
15. The advantages of using triple-marker screening for chromosomal abnormalities.
Kellner LH; Weiss RR; Weiner Z; Neuer M; Martin GM; Schulman H; Lipper S
Am J Obstet Gynecol; 1995 Mar; 172(3):831-6. PubMed ID: 7534448
[TBL] [Abstract][Full Text] [Related]
16. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum analyte levels in pregnancies with fetal Down syndrome resulting from translocations.
Saller DN; Canick JA; Kellner LH; Rose NC; Garza J; French CA; Mooney RA
Am J Obstet Gynecol; 1997 Oct; 177(4):879-81. PubMed ID: 9369838
[TBL] [Abstract][Full Text] [Related]
18. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
19. Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
Duric K; Skrablin S; Lesin J; Kalafatic D; Kuvacic I; Suchanek E
Eur J Obstet Gynecol Reprod Biol; 2003 Sep; 110(1):12-5. PubMed ID: 12932863
[TBL] [Abstract][Full Text] [Related]
20. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
